Incidence and mortality of new-onset glucose disorders in peritoneal dialysis patients in China: a meta-analysis

BMC Nephrology

Table 1 Baseline characteristics of patients in the trials included in the meta-analysis

Study	Study design	Dialysis modality	No. of patients	Male/female	Age (mean ± SD, y)	Follow-up (months)	NOS score
Tien KJ [1]	Cohort	PD/HD	3346	1398/1948	NA	53.2	7
Tien KJ [1]	Cohort	PD/HD	22,820	10,784/12036	NA
Szeto CC [11]	Cohort	CAPD	252	135/117	59 ± 13	45.4 ± 26.5	6
Yu XF [27]	Cohort	CAPD	145	60/85	62 ± 15	48	6
Wang IK [28]	Cohort	PD/HD	6177	2665/3512	51.0	49.44 ± 34.32	8
Wang IK [28]	Cohort	PD/HD	6177	2726/3451	51.2	52.36 ± 37.2	7
Wu PP [29]	Cohort	PD/HD	2228	1096/1132	60.29 ± 16.43	64.2 ± 47.04	7
Wu PP [29]	Cohort	PD/HD	8912	4384/4528	60.29 ± 16.43	73.68 ± 47.4
Dong J [30]	Cohort	PD	32	9/23	61 ± 12.5	32.4 (12.9–60.8)	6
Dong J [30]	Cohort	PD	580	256/324	55.2 ± 15.4
Chou CY [31]	Cohort	PD/HD	2548	916/1632	50.2 ± 14.7	70	7
Chou CY [31]	Cohort	PD/HD	10,192	3692/6500	50.3 ± 14.5
Cheng SC [32]	Cohort	CAPD	14	5/9	46.4 ± 12.0	39.9 ± 28.3	6
Cheng SC [32]	Cohort	CAPD	21	7/14	42.4 ± 9.4	60.5 ± 37.8
Song ZP [33]	Cohort	PD	42	NA	60.2 ± 2.3	NA	6
Song ZP [33]	Cohort	PD	42	NA	60.2 ± 2.3
Yang G [34]	Cohort	PD	40	NA	58.4 ± 4.7	NA	6
Yang G [34]	Cohort	PD	42	NA	58.4 ± 4.7
Ye SH [35]	Cohort	PD	44	24/20	60.14 ± 2.69	NA	6
Ye SH [35]	Cohort	PD	44	25/19	60.78 ± 2.98
Peng XY [36]	Cohort	CAPD	138	83/55	57 (46–71)	NA	7
Peng XY [36]	Cohort	CAPD	69	38/31	56 (42–71)
Xia P [37]	Cohort	CAPD/APD	442	228/214	58.4 ± 15.6	NA	6
Xia P [37]	Cohort	CAPD/APD	92	53/39	56.7 ± 16.0	NA
Fei JY [38]	Cohort	CAPD	286	148/138	58 (13–85)	3–120	6
Li Y [39]	Cohort	PD	577	280/297	58.9 ± 15.5	NA	6

Abbreviation: SD standard deviation, PD Peritoneal dialysis, HD hemodialysis, CAPD continuous ambulatory PD, APD, automated PD

ISSN: 1471-2369